What is the name of the tumor that arises after trauma, commonly in the abdominal wall muscles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Desmoid Tumor (Aggressive Fibromatosis)

The tumor you're describing is a desmoid tumor, also known as aggressive fibromatosis, which characteristically develops in the abdominal wall muscles following trauma, particularly surgical trauma such as cesarean sections. 1, 2

Key Characteristics

Desmoid tumors are benign but locally aggressive myofibroblastic neoplasms that arise from musculoaponeurotic structures. They have several distinctive features:

  • Post-traumatic origin: Frequently associated with surgical trauma, particularly abdominal surgery including cesarean sections, appendectomy, and other abdominal procedures 2, 3, 4
  • Location: Most commonly arise in the rectus abdominis muscle and abdominal wall (24% of all desmoid tumors occur in the abdominal wall) 1
  • Demographics: Predominantly affect women of childbearing age (2nd-4th decade of life), especially those with pregnancy history 3, 5
  • Behavior: Locally infiltrative with NO metastatic potential—this is critical for prognosis 6, 7

Clinical Presentation

Look for these specific features:

  • Firm, hard-elastic mass in the abdominal wall
  • Rapid growth over 6-24 months 8
  • Can reach large sizes (median diameter 163 mm in one series) 8
  • Often presents years after the inciting trauma (commonly 2-4 years post-surgery) 2

Diagnostic Approach

MRI is the preferred imaging modality and shows characteristic findings:

  • T2 hypointensity (due to collagen deposition) 2
  • Fascial infiltration along facial planes 9
  • Well-defined but infiltrative borders 2

Core needle biopsy is essential when diagnosis is uncertain or before considering neoadjuvant therapy 6. Histology shows:

  • Nuclear beta-catenin positivity (CTNNB1 mutation in sporadic cases) 7
  • Well-differentiated fibrous tissue 4

Critical Management Paradigm Shift

Active surveillance ("watchful waiting") is now the first-line approach, NOT immediate surgery 7, 9. This represents a fundamental change from historical management:

Initial Management Strategy:

  1. Start with observation for asymptomatic or minimally symptomatic tumors 9

    • 50% progression-free survival at 5 years with watchful waiting 9
    • 20-30% undergo spontaneous regression 9
    • Abdominal wall location has particularly favorable outcomes 9
  2. Medical therapy is preferred over surgery for progressive disease:

    • NSAIDs for symptomatic relief 2
    • Systemic options include sorafenib, pegylated liposomal doxorubicin, pazopanib, or low-dose vinorelbine 7
    • Nirogacestat (γ-Secretase Inhibitor) shows benefit in phase 3 trials 7
  3. Surgery is reserved for specific situations 7, 9:

    • Exception: Abdominal wall desmoids have low recurrence rates after surgery and may be treated surgically upfront 7, 9
    • When surveillance fails and tumor progresses
    • When function can be preserved
    • Aim for complete en bloc resection, but surgical margins do NOT consistently correlate with recurrence 9

Important Caveats

Avoid these pitfalls:

  • Don't rush to surgery—this is NOT a sarcoma requiring wide margins 9
  • Pregnancy does NOT increase recurrence risk after treatment 5
  • Incomplete histological resection does NOT necessarily predict recurrence 5
  • Adjuvant radiotherapy should NOT be routine for abdominal wall desmoids 6

Association with Genetic Syndromes

Screen for Gardner syndrome/FAP if patient has:

  • Young age, male gender, abdominal site
  • Family history of cancer
  • Absence of CTNNB1 mutation 7

Desmoid tumors occur in 7.5-16% of FAP patients, with abdominal surgery and APC mutation site as significant risk factors 1. The median age at diagnosis is 31 years 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.